Endologix investigates new Powerlink graft in large diameter aneurysm necks:
This article was originally published in Clinica
Seeking to broaden the market for its Powerlink stent graft for treating abdominal aortic aneurysm (AAA), Endologix has begun a US clinical trial to test a modified version the device designed to treat aneurysms with larger neck diameters. If approved, the new device could become the first endoluminal stent graft (ELG) for use in aneurysms with neck diameters up to 32mm, according to the Irvine, California firm, which has already received FDA approval to sell the original form of the product. "The Powerlink 34mm system has the ability to expand the universe of AAA patients suitable for minimally invasive ELGs as approximately 5-10% of those evaluated are excluded due to a large aortic neck diameter," said Paul McCormick, Endologix' president and CEO.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.